Oil India shares jumped over 5% after strong Q1FY27 results prompted Emkay Global to upgrade the stock to ‘Buy’. The brokerage cited attractive valuations, higher crude production and improving gas evacuation prospects. Elara Capital also retained its ‘Buy’ rating, while Nomura and Motilal Oswal maintained neutral views on the stock.
Aarti Pharmalabs shares rally over 33% in two days post Q1 results. What is driving the surge?
Aarti Pharmalabs shares have surged 33% in two days after the company reported a 65.4% year-on-year rise in Q1FY27 profit and 38.7% growth in revenue.